EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of iron biomarkers in differentiating menopausal status: Findings from CoLaus and PREVEND

Lum Kastrati, Dion Groothof, Hugo G Quezada-Pinedo, Hamidreza Raeisi-Dehkordi, Lia Bally, Martin H De Borst, Stephan J L Bakker, Pedro-Marques Vidal, Michele F Eisenga, Taulant Muka

Maturitas · 2024

DOI: 10.1016/j.maturitas.2023.107872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Maturitas, 2024. Verfasst von Lum Kastrati und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; Graduate School for Health Sciences, University of Bern, B…. Hauptthemen laut MEDLINE: Hepcidins, Iron. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepcidinsIronFemaleHumansBiomarkersCross-Sectional StudiesFerritinsMenopauseTransferrin

Stichwörter der Autor:innen

FerritinHepcidinIronMenopauseTransferrin

Substanzen

BiomarkersFerritinsHepcidinsIronTransferrin

Autor:innen und Institutionen

  • Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; Graduate School for Health Sciences, University of Bern, Bern, Switzerland; Department of Diabetes, Endocrinology, Nutritional M…
  • Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, 9713, GZ, Groningen, the Netherlands.
  • The Generation R Study Group, University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism UDEM, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Department of Medicine, internal medicine, Lausanne university hospital (CHUV), University of Lausanne, Lausanne, Switzerland.

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Kastrati, L., Groothof, D., Quezada-Pinedo, H. G., Raeisi-Dehkordi, H., Bally, L., De Borst, M. H., Bakker, S. J. L., Vidal, P. M., Eisenga, M. F., & Muka, T. (2024). Utility of iron biomarkers in differentiating menopausal status: Findings from CoLaus and PREVEND. Maturitas. https://doi.org/10.1016/j.maturitas.2023.107872

Vancouver

Kastrati L, Groothof D, Quezada-Pinedo HG, Raeisi-Dehkordi H, Bally L, De Borst MH, et al. Utility of iron biomarkers in differentiating menopausal status: Findings from CoLaus and PREVEND. Maturitas. 2024. doi:10.1016/j.maturitas.2023.107872

BibTeX
@article{Kastrati2024,
  author = {Kastrati, Lum and Groothof, Dion and Quezada-Pinedo, Hugo G and Raeisi-Dehkordi, Hamidreza and Bally, Lia and De Borst, Martin H and Bakker, Stephan J L and Vidal, Pedro-Marques and Eisenga, Michele F and Muka, Taulant},
  title = {Utility of iron biomarkers in differentiating menopausal status: Findings from CoLaus and PREVEND},
  journal = {Maturitas},
  year = {2024},
  doi = {10.1016/j.maturitas.2023.107872}
}
Kostenlos starten →